Table 2 The ECMO details and intervention of IVC thrombosis
| Â | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 |
|---|---|---|---|---|---|
ECMO details | |||||
 Circuit | VA | VA | VV | VV | VV |
 Catheter position | Femoral Artery- Femoral Vein | Femoral Artery- Femoral Vein | Internal jugular vein - femoral vein | Internal jugular vein - femoral vein | Internal jugular vein - femoral vein |
 Femoral vein catheter size, F | 18 | 20 | 21 | 21 | 21 |
 Femoral artery catheter size, F | 16 | 18 | - | - | - |
 Internal jugular vein catheter size, F | - | - | 19 | 19 | 18 |
 Average flow, L/min | 3.28 ± 0.50 | 2.80 ± 0.29 | 5.13 ± 0.31 | 4.50 ± 0.04 | 4.14 ± 0.10 |
 Duration, d | 5 | 9 | 10 | 25 | 5 |
 Anticoagulant | No | UFH Nafamostat mesylate | UFH | Argatroban | Nafamostat mesylate |
 CRP, mg/L | 11.70 ± 4.26 | 109.33 ± 77.26 | 63.00 ± 21.42 | 128.44 ± 55.85 | 88.53 ± 29.88 |
 PCT, ng/mL | 14.66 ± 7.47 | 4.30 ± 2.01 | 62.01 ± 53.02 | 5.95 ± 4.47 | 24.30 ± 8.23 |
 Platelets, *10^9/L | 69.00 ± 16.17 | 166.85 ± 86.14 | 48.50 ± 11.65 | 83.38 ± 38.79 | 112.33 ± 9.46 |
 D-Dimer, mg/L | 20.00 ± 0.00 | 16.03 ± 3.93 | 17.11 ± 2.53 | 6.48 ± 7.63 | 6.56 ± 2.35 |
 PT, s | 22.45 ± 9.48 | 16.47 ± 3.55 | 19.70 ± 2.92 | 19.26 ± 14.16 | 15.76 ± 0.53 |
 APTT, s | 44.33 ± 3.36 | 39.65 ± 4.70 | 39.08 ± 4.40 | 49.2 ± 3.92 | 42.47 ± 6.90 |
 FIB, g/L | 1.84 ± 0.46 | 3.30 ± 0.81 | 2.26 ± 0.66 | 3.14 ± 0.62 | 3.29 ± 0.25 |
Intervention | Enoxaparin IVC filter | UFH Enoxaparin CDT | UFH | Argatroban CDT | Enoxaparin |
IVC thrombosis | Disappear | Disappear | Disappear | Shrink | Shrink |
Outcome | Survival | Survival | Survival | Survival | Survival |